Skip to main content
. 2022 May 6;24(2):144–153. doi: 10.7461/jcen.2022.E2021.12.003

Table 2.

Angiographic outcomes and embolization complications

All patients, n (%): N=30
Angiographic outcomes n-BCA group Onyx group
n=12 n=18
Initial volume, mL
 Median (Q1, Q3) 3.5 (1.1, 9.9) 4.3 (1.9, 11)
Total % devascularization
 Median (Q1, Q3) 52 (31, 67) 51 (27, 86)
 <25%, n (%) 2 (17) 3 (17)
 25-49% 3 (25) 5 (28)
 50-75% 5 (42) 4 (22)
 75-99% 1 (8) 5 (28)
 >99% 1 (8) 1 (5)
Need for >1 embolization
 Yes, n (%) 6 (50) 4 (22)
Total number of sessions
 n 22 25
Number of sessions per person
 Mean±SD 1.8±1.0 1.4±0.8
Total number of pedicles
 n 42 45
Number of pedicles per person
 Mean±SD 3.5±1.9 2.6±2.0
Number of pedicles per session
 Mean±SD 2.1±0.9 1.9±1.1
% devascularization per pedicle
 Mean±SD 16±14 34±29
% devascularization by objective Both groups:Mean±S``D n=30
 Curative (n=6) 61±34
 Non-Curative: Palliative (n=1) 79±N/A
 Non-Curative: Targeted (n=5) 48±19
 Non-Curative: Pre-surgery (n=12) 47±29
 Non-Curative: Pre-SRS (n=6) 54±36
Complications, n (%) n-BCA group Onyx group
n=12 n=18
Minor 1 (8.3) 0 (0)
Major 1 (8.3) 0 (0)
Mortality 0 (0) 0 (0)
Total 2 (17) 0 (0)

Note: Summary of the embolization objectives, angiographic changes, and complication rates associated with embolization treatments.

n-BCA, n-butyl cyanoacrylate; SRS, stereotactic radiosurgery